Skip to main content
Log in

Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the diagnostic performance of apparent diffusion coefficient (ADC) parameters by region of interest (ROI) methods in differentiating mass-forming autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC).

Methods

The institutional review board approved this retrospective study and the requirement for informed consent was waived. Twenty-three patients with mass-forming AIP and 144 patients with PDAC underwent diffusion-weighted imaging with b-values of 0 s/mm2 and 800 s/mm2. The minimum, maximum, and mean ADC values obtained by placing ROIs within lesions and percentile ADC values (10th, 25th, 50th, 75th, and 90th) from entire-lesion histogram analysis were compared between the two groups by using Mann–Whitney U tests. The diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis.

Results

The minimum, maximum, and mean ADC values were significantly different between mass-forming AIP and PDAC groups. ROC curve analysis showed that the maximum ADC had the highest diagnostic performance (0.92), while the minimum ADC value had the lowest diagnostic performance (0.72). The AUC of minimum ADC was significantly lower than that of maximum or mean ADC (P < 0.0001, P < 0.0001). The AUC was lowest in 10th percentile ADC value and highest in 90th percentile value. The AUC increased along with the increase of percentile values.

Conclusion

Either the maximum or mean ADC value was effective in differentiating mass-forming AIP from the PDAC group, while the minimum ADC value might not be recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AIP:

Autoimmune pancreatitis

MRCP:

Magnetic resonance cholangiopancreatography

PDAC:

Pancreatic ductal adenocarcinoma

ADC:

Apparent diffusion coefficient

ROI:

Region of interest

References

  1. Finkelberg DL, Brugge WR (2006) Autoimmune Pancreatitis. New England Journal of Medicine 355: 2670-2676. https://org.doi/full/10.1056/NEJMoa0903068

  2. Khandelwal A, Inoue D, Takahashi N (2020) Autoimmune pancreatitis: an update. Abdom Radiol 45:1359–1370. https://doi.org/10.1007/s00261-019-02275-x

  3. Chari ST (2007) Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol 42:39–41. https://doi.org/10.1007/s00535-007-2046-8

  4. Shimosegawa T, Chari ST, Frulloni L, et al (2011) International Consensus Diagnostic Criteria for Autoimmune Pancreatitis. 40 (3):352-358. https://doi.org/10.1097/MPA.0b013e3182142fd2

  5. The Japan Pancreas Society; The Research Program on Intractable Diseases from the Ministry of Labor and Welfare of Japan. [Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2018 (proposal)—revision of Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2011. J Jpn Pancreas (Suizo) 2018 33:902–913. https://www.jstage.jst.go.jp/article/suizo/33/6/33_902/_pdf/-char/ja

  6. Chari ST, Smyrk TC, Levy MJ, et al (2006) Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience. Clinical Gastroenterology and Hepatology 4:1010–1016. https://doi.org/10.1016/j.cgh.2006.05.017

  7. Kamisawa T, Takuma K, Anjiki H, et al (2010) Differentiation of Autoimmune Pancreatitis From Pancreatic Cancer by Diffusion-Weighted MRI: American Journal of Gastroenterology 105:1870–1875. https://doi.org/10.1038/ajg.2010.87

  8. Takuma K (2012) Strategy to differentiate autoimmune pancreatitis from pancreas cancer. WJG 18 (10):1015-1020. https://doi.org/10.3748/wjg.v18.i10.1015

  9. Hoshimoto S, Aiura K, Tanaka M, et al (2016) Mass-forming type 1 autoimmune pancreatitis mimicking pancreatic cancer: Mass-forming autoimmune pancreatitis. Journal of Digestive Diseases 17:202–209. https://doi.org/10.1111/1751-2980.12316

  10. Muhi A, Ichikawa T, Motosugi U, et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: Differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836. https://doi.org/10.1002/jmri.22881

  11. Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society, Kawa S, Okazaki K, et al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 45:355–369. https://doi.org/10.1007/s00535-009-0197-5

  12. Shankar A, Srinivas S, Kalyanasundaram S (2020) Icicle sign: autoimmune pancreatitis. Abdom Radiol 45:245–246. https://doi.org/10.1007/s00261-019-02323-6

  13. Barral M, Taouli B, Guiu B, et al (2015) Diffusion-weighted MR Imaging of the Pancreas: Current Status and Recommendations. Radiology 274:45–63. https://doi.org/10.1148/radiol.14130778

  14. Choi S-Y, Kim SH, Kang TW, et al (2016) Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings. American Journal of Roentgenology 206:291–300. https://doi.org/10.2214/AJR.15.14974

  15. Taniguchi T, Kobayashi H, Nishikawa K, et al (2009) Diffusion-weighted magnetic resonance imaging in autoimmune pancreatitis. Jpn J Radiol 27:138–142. https://doi.org/10.1007/s11604-008-0311-2

  16. Hirano M, Satake H, Ishigaki S, et al (2012) Diffusion-Weighted Imaging of Breast Masses: Comparison of Diagnostic Performance Using Various Apparent Diffusion Coefficient Parameters. American Journal of Roentgenology 198:717–722. https://doi.org/10.2214/AJR.11.7093

  17. Mori N, Ota H, Mugikura S, et al (2013) Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters. European Radiology 23:2705–2712. https://doi.org/10.1007/s00330-013-2902-2

  18. Murakami R, Hirai T, Sugahara T, et al (2009) Grading Astrocytic Tumors by Using Apparent Diffusion Coefficient Parameters: Superiority of a One-versus Two-Parameter Pilot Method1. Radiology 251:838–845. https://doi.org/10.1148/radiol.2513080899

  19. Sugahara T, Korogi Y, Kochi M, et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60. https://doi.org/10.1007/s11604-011-0047-2

  20. Herneth AM, Guccione S, Bednarski M (2003) Apparent Diffusion Coefficient: a quantitative parameter for in vivo tumor characterization. European Journal of Radiology 45:208–213. https://doi.org/10.1016/S0720-048X(02)00310-8

  21. Lyng H, Haraldseth O, Rofstad EK (2000) Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med. 43(6):828-36. https://doi.org/10.1002/1522-2594(200006)43:6%3c828::AID-MRM8%3e3.0.CO;2-P

  22. Ma X, Zhao X, Ouyang H, et al (2014) Quantified ADC histogram analysis: a new method for differentiating mass-forming focal pancreatitis from pancreatic cancer. Acta Radiologica 55:785–792. https://doi.org/10.1177/0284185113509264

  23. Kang Y, Choi SH, Kim Y-J, et al (2011) Gliomas: Histogram Analysis of Apparent Diffusion Coefficient Maps with Standard- or High-b-Value Diffusion-weighted MR Imaging—Correlation with Tumor Grade. Radiology 261:882–890. https://doi.org/10.1148/radiol.11110686

  24. Landis JR, Koch GG (1977) The Measurement of Observer Agreement for Categorical Data. Biometrics 33:159. https://doi.org/10.2307/2529310

  25. Yoon SE, Byun JH, Kim KA, et al (2010) Pancreatic ductal adenocarcinoma with intratumoral cystic lesions on MRI: correlation with histopathological findings. BJR 83:318–326. https://doi.org/10.1259/bjr/69770140

  26. Sugiyama Y, Fujinaga Y, Kadoya M, et al (2012) Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer. Jpn J Radiol 30:296–309. https://doi.org/10.1007/s11604-011-0047-2

  27. Feuerlein S, Pauls S, Juchems MS, et al (2009) Pitfalls in Abdominal Diffusion-Weighted Imaging: How Predictive is Restricted Water Diffusion for Malignancy. American Journal of Roentgenology 193:1070–1076. https://doi.org/10.2214/AJR.08.2093

  28. Kyriazi S, Collins DJ, Messiou C, et al (2011) Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response with Diffusion-weighted MR Imaging–Value of Histogram Analysis of Apparent Diffusion Coefficients. Radiology 261:182–192. https://doi.org/10.1148/radiol.11110577

  29. Mori N, Ota H, Mugikura S, et al (2014) Luminal-Type Breast Cancer: Correlation of Apparent Diffusion Coefficients with the Ki-67 Labeling Index. Radiology 274:66–73. https://doi.org/10.1148/radiol.14140283

  30. Kim HJ, Kim YK, Jeong WK, et al (2015) Pancreatic duct “Icicle sign” on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas. Eur Radiol 25:1551–1560. https://doi.org/10.1007/s00330-014-3548-4

  31. De Robertis R, Cardobi N, Ortolani S, et al (2019) Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization. Abdom Radiol 44:131–139. https://doi.org/10.1007/s00261-018-1684-z

  32. Kim B, Lee SS, Sung YS, et al (2017) Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies: IVIM DWI of the Pancreas. J Magn Reson Imaging 45:260–269. https://doi.org/10.1002/jmri.25334

  33. Okazaki K, Chari ST, Frulloni L, et al (2017) International consensus for the treatment of autoimmune pancreatitis. Pancreatology 17:1–6. https://doi.org/10.1016/j.pan.2016.12.003

Download references

Acknowledgements

The authors thank Mayu Sawaguchi, Yo Oguma, Kyuhei Takahashi, Naoko Hirose, Kanako Shibui and Kazufumi Watanabe of Tohoku University, for their kind assistance in data collection.

Funding

The funding was provided by JSPS KAKENHI 18K07742.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoko Mori.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Ethical approval

This study was approved by the Institutional Review Board.

Informed consent

Informed consent was waived.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, H., Mori, N., Hamada, S. et al. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma. Abdom Radiol 46, 1640–1647 (2021). https://doi.org/10.1007/s00261-020-02795-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02795-x

Keywords

Navigation